Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilisation of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer: A Prospective Cohort Study.

NCT00912080 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT00912080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00912080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilisation of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer: A Prospective Cohort Study.
Lead sponsor
Institut Paoli-Calmettes
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2007
Completion date
May 31, 2015
Enrollment
375 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer